 | • レポートコード：MRC2102QY9458 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の筋弛緩薬市場について種類別（骨格筋弛緩薬、顔面筋弛緩薬）、用途別（病院薬局、小売薬局、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・筋弛緩薬市場の概要 ・世界の主要地域別筋弛緩薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の筋弛緩薬市場規模2015-2026：種類別（骨格筋弛緩薬、顔面筋弛緩薬） ・世界の筋弛緩薬市場規模2015-2026：用途別（病院薬局、小売薬局、その他） ・筋弛緩薬の米国市場規模2015-2020 ・筋弛緩薬のヨーロッパ市場規模2015-2020 ・筋弛緩薬の中国市場規模2015-2020 ・筋弛緩薬の日本市場規模2015-2020 ・筋弛緩薬の東南アジア市場規模2015-2020 ・筋弛緩薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・筋弛緩薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・筋弛緩薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Muscle Relaxant Drugs Market
The global Muscle Relaxant Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Muscle Relaxant Drugs Scope and Market Size
The global Muscle Relaxant Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Muscle Relaxant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Muscle Relaxant Drugs market is segmented into
Skeletal Muscle Relaxant Drugs
Facial Muscle Relaxant Drugs
Segment by Application, the Muscle Relaxant Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Other
The Muscle Relaxant Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Muscle Relaxant Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Muscle Relaxant Drugs Market Share Analysis
Muscle Relaxant Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Muscle Relaxant Drugs business, the date to enter into the Muscle Relaxant Drugs market, Muscle Relaxant Drugs product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Allergan
Ipsen Group
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Par Sterile Products
Acorda Therapeutics
SteriMax Inc
Emcure Pharmaceuticals
Upsher-Smith Laboratories
Orient Pharma
Daewoong Pharmaceutical
1 Muscle Relaxant Drugs Market Overview
1.1 Muscle Relaxant Drugs Product Scope
1.2 Muscle Relaxant Drugs Segment by Type
1.2.1 Global Muscle Relaxant Drugs Sales by Type (2020-2026)
1.2.2 Skeletal Muscle Relaxant Drugs
1.2.3 Facial Muscle Relaxant Drugs
1.3 Muscle Relaxant Drugs Segment by Application
1.3.1 Global Muscle Relaxant Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Muscle Relaxant Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Muscle Relaxant Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Muscle Relaxant Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Muscle Relaxant Drugs Price Trends (2015-2026)
2 Muscle Relaxant Drugs Estimate and Forecast by Region
2.1 Global Muscle Relaxant Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Muscle Relaxant Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Muscle Relaxant Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Muscle Relaxant Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Muscle Relaxant Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Muscle Relaxant Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Muscle Relaxant Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Muscle Relaxant Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Muscle Relaxant Drugs Estimates and Projections (2015-2026)
2.4.3 China Muscle Relaxant Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Muscle Relaxant Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Muscle Relaxant Drugs Estimates and Projections (2015-2026)
2.4.6 India Muscle Relaxant Drugs Estimates and Projections (2015-2026)
3 Global Muscle Relaxant Drugs Competition Landscape by Players
3.1 Global Top Muscle Relaxant Drugs Players by Sales (2015-2020)
3.2 Global Top Muscle Relaxant Drugs Players by Revenue (2015-2020)
3.3 Global Muscle Relaxant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Muscle Relaxant Drugs as of 2019)
3.4 Global Muscle Relaxant Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Muscle Relaxant Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Muscle Relaxant Drugs Players (Opinion Leaders)
4 Global Muscle Relaxant Drugs Market Size by Type
4.1 Global Muscle Relaxant Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Muscle Relaxant Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Muscle Relaxant Drugs Price by Type (2015-2020)
4.2 Global Muscle Relaxant Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Muscle Relaxant Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Muscle Relaxant Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Muscle Relaxant Drugs Price Forecast by Type (2021-2026)
5 Global Muscle Relaxant Drugs Market Size by Application
5.1 Global Muscle Relaxant Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Muscle Relaxant Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Muscle Relaxant Drugs Price by Application (2015-2020)
5.2 Global Muscle Relaxant Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Muscle Relaxant Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Muscle Relaxant Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Muscle Relaxant Drugs Price Forecast by Application (2021-2026)
6 United States Muscle Relaxant Drugs Market Facts & Figures
6.1 United States Muscle Relaxant Drugs Sales Market Share by Company (2015-2020)
6.2 United States Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
6.3 United States Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
7 Europe Muscle Relaxant Drugs Market Facts & Figures
7.1 Europe Muscle Relaxant Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
8 China Muscle Relaxant Drugs Market Facts & Figures
8.1 China Muscle Relaxant Drugs Sales Market Share by Company (2015-2020)
8.2 China Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
8.3 China Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
9 Japan Muscle Relaxant Drugs Market Facts & Figures
9.1 Japan Muscle Relaxant Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Muscle Relaxant Drugs Market Facts & Figures
10.1 Southeast Asia Muscle Relaxant Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
11 India Muscle Relaxant Drugs Market Facts & Figures
11.1 India Muscle Relaxant Drugs Sales Market Share by Company (2015-2020)
11.2 India Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
11.3 India Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Muscle Relaxant Drugs Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Muscle Relaxant Drugs Products Offered
12.1.5 Pfizer Recent Development
12.2 Allergan
12.2.1 Allergan Corporation Information
12.2.2 Allergan Business Overview
12.2.3 Allergan Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Allergan Muscle Relaxant Drugs Products Offered
12.2.5 Allergan Recent Development
12.3 Ipsen Group
12.3.1 Ipsen Group Corporation Information
12.3.2 Ipsen Group Business Overview
12.3.3 Ipsen Group Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Ipsen Group Muscle Relaxant Drugs Products Offered
12.3.5 Ipsen Group Recent Development
12.4 Teva Pharmaceuticals
12.4.1 Teva Pharmaceuticals Corporation Information
12.4.2 Teva Pharmaceuticals Business Overview
12.4.3 Teva Pharmaceuticals Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Teva Pharmaceuticals Muscle Relaxant Drugs Products Offered
12.4.5 Teva Pharmaceuticals Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Business Overview
12.5.3 Novartis Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Muscle Relaxant Drugs Products Offered
12.5.5 Novartis Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Business Overview
12.6.3 Johnson & Johnson Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Muscle Relaxant Drugs Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Takeda Pharmaceutical
12.7.1 Takeda Pharmaceutical Corporation Information
12.7.2 Takeda Pharmaceutical Business Overview
12.7.3 Takeda Pharmaceutical Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Takeda Pharmaceutical Muscle Relaxant Drugs Products Offered
12.7.5 Takeda Pharmaceutical Recent Development
12.8 Sun Pharmaceutical Industries
12.8.1 Sun Pharmaceutical Industries Corporation Information
12.8.2 Sun Pharmaceutical Industries Business Overview
12.8.3 Sun Pharmaceutical Industries Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sun Pharmaceutical Industries Muscle Relaxant Drugs Products Offered
12.8.5 Sun Pharmaceutical Industries Recent Development
12.9 Merz Pharma
12.9.1 Merz Pharma Corporation Information
12.9.2 Merz Pharma Business Overview
12.9.3 Merz Pharma Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Merz Pharma Muscle Relaxant Drugs Products Offered
12.9.5 Merz Pharma Recent Development
12.10 Mylan
12.10.1 Mylan Corporation Information
12.10.2 Mylan Business Overview
12.10.3 Mylan Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mylan Muscle Relaxant Drugs Products Offered
12.10.5 Mylan Recent Development
12.11 Fresenius Kabi
12.11.1 Fresenius Kabi Corporation Information
12.11.2 Fresenius Kabi Business Overview
12.11.3 Fresenius Kabi Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Fresenius Kabi Muscle Relaxant Drugs Products Offered
12.11.5 Fresenius Kabi Recent Development
12.12 Endo International
12.12.1 Endo International Corporation Information
12.12.2 Endo International Business Overview
12.12.3 Endo International Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Endo International Muscle Relaxant Drugs Products Offered
12.12.5 Endo International Recent Development
12.13 Par Sterile Products
12.13.1 Par Sterile Products Corporation Information
12.13.2 Par Sterile Products Business Overview
12.13.3 Par Sterile Products Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Par Sterile Products Muscle Relaxant Drugs Products Offered
12.13.5 Par Sterile Products Recent Development
12.14 Acorda Therapeutics
12.14.1 Acorda Therapeutics Corporation Information
12.14.2 Acorda Therapeutics Business Overview
12.14.3 Acorda Therapeutics Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Acorda Therapeutics Muscle Relaxant Drugs Products Offered
12.14.5 Acorda Therapeutics Recent Development
12.15 SteriMax Inc
12.15.1 SteriMax Inc Corporation Information
12.15.2 SteriMax Inc Business Overview
12.15.3 SteriMax Inc Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 SteriMax Inc Muscle Relaxant Drugs Products Offered
12.15.5 SteriMax Inc Recent Development
12.16 Emcure Pharmaceuticals
12.16.1 Emcure Pharmaceuticals Corporation Information
12.16.2 Emcure Pharmaceuticals Business Overview
12.16.3 Emcure Pharmaceuticals Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Emcure Pharmaceuticals Muscle Relaxant Drugs Products Offered
12.16.5 Emcure Pharmaceuticals Recent Development
12.17 Upsher-Smith Laboratories
12.17.1 Upsher-Smith Laboratories Corporation Information
12.17.2 Upsher-Smith Laboratories Business Overview
12.17.3 Upsher-Smith Laboratories Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Upsher-Smith Laboratories Muscle Relaxant Drugs Products Offered
12.17.5 Upsher-Smith Laboratories Recent Development
12.18 Orient Pharma
12.18.1 Orient Pharma Corporation Information
12.18.2 Orient Pharma Business Overview
12.18.3 Orient Pharma Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Orient Pharma Muscle Relaxant Drugs Products Offered
12.18.5 Orient Pharma Recent Development
12.19 Daewoong Pharmaceutical
12.19.1 Daewoong Pharmaceutical Corporation Information
12.19.2 Daewoong Pharmaceutical Business Overview
12.19.3 Daewoong Pharmaceutical Muscle Relaxant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Daewoong Pharmaceutical Muscle Relaxant Drugs Products Offered
12.19.5 Daewoong Pharmaceutical Recent Development
13 Muscle Relaxant Drugs Manufacturing Cost Analysis
13.1 Muscle Relaxant Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Muscle Relaxant Drugs
13.4 Muscle Relaxant Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Muscle Relaxant Drugs Distributors List
14.3 Muscle Relaxant Drugs Customers
15 Market Dynamics
15.1 Muscle Relaxant Drugs Market Trends
15.2 Muscle Relaxant Drugs Opportunities and Drivers
15.3 Muscle Relaxant Drugs Market Challenges
15.4 Muscle Relaxant Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Muscle Relaxant Drugs Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Muscle Relaxant Drugs Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Muscle Relaxant Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Muscle Relaxant Drugs Sales (K Units) by Region (2015-2020)
Table 5. Global Muscle Relaxant Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Muscle Relaxant Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Muscle Relaxant Drugs Revenue Share by Region (2015-2020)
Table 8. Global Muscle Relaxant Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Muscle Relaxant Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Muscle Relaxant Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Muscle Relaxant Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Muscle Relaxant Drugs (K Units) of Key Companies (2015-2020)
Table 13. Global Muscle Relaxant Drugs Sales Share by Company (2015-2020)
Table 14. Global Muscle Relaxant Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Muscle Relaxant Drugs Revenue Share by Company (2015-2020)
Table 16. Global Muscle Relaxant Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Muscle Relaxant Drugs as of 2019)
Table 17. Global Muscle Relaxant Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Muscle Relaxant Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Muscle Relaxant Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Muscle Relaxant Drugs Players
Table 22. Global Muscle Relaxant Drugs Sales (K Units) by Type (2015-2020)
Table 23. Global Muscle Relaxant Drugs Sales Share by Type (2015-2020)
Table 24. Global Muscle Relaxant Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Muscle Relaxant Drugs Price (K Units) by Type (2015-2020)
Table 26. Global Muscle Relaxant Drugs Sales Share by Type (2021-2026)
Table 27. Global Muscle Relaxant Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Muscle Relaxant Drugs Revenue Share by Type (2021-2026)
Table 29. Global Muscle Relaxant Drugs Price (K Units) by Type (2021-2026)
Table 30. Global Muscle Relaxant Drugs Sales (K Units) by Application (2015-2020)
Table 31. Global Muscle Relaxant Drugs Sales Share by Application (2015-2020)
Table 32. Global Muscle Relaxant Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Muscle Relaxant Drugs Price (K Units) by Application (2015-2020)
Table 34. Global Muscle Relaxant Drugs Sales (K Units) by Application (2021-2026)
Table 35. Global Muscle Relaxant Drugs Sales Share by Application (2021-2026)
Table 36. Global Muscle Relaxant Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Muscle Relaxant Drugs Revenue Share by Application (2021-2026)
Table 38. Global Muscle Relaxant Drugs Price (K Units) by Application (2021-2026)
Table 39. United States Muscle Relaxant Drugs Sales (K Units) by Company (2015-2020)
Table 40. United States Muscle Relaxant Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Muscle Relaxant Drugs Sales (K Units) by Type (2015-2020)
Table 42. United States Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Muscle Relaxant Drugs Sales (K Units) by Application (2015-2020)
Table 44. United States Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Muscle Relaxant Drugs Sales (K Units) by Company (2015-2020)
Table 46. Europe Muscle Relaxant Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Muscle Relaxant Drugs Sales (K Units) by Type (2015-2020)
Table 48. Europe Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Muscle Relaxant Drugs Sales (K Units) by Application (2015-2020)
Table 50. Europe Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 51. China Muscle Relaxant Drugs Sales (K Units) by Company (2015-2020)
Table 52. China Muscle Relaxant Drugs Sales Market Share by Company (2015-2020)
Table 53. China Muscle Relaxant Drugs Sales (K Units) by Type (2015-2020)
Table 54. China Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 55. China Muscle Relaxant Drugs Sales (K Units) by Application (2015-2020)
Table 56. China Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Muscle Relaxant Drugs Sales (K Units) by Company (2015-2020)
Table 58. Japan Muscle Relaxant Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Muscle Relaxant Drugs Sales (K Units) by Type (2015-2020)
Table 60. Japan Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Muscle Relaxant Drugs Sales (K Units) by Application (2015-2020)
Table 62. Japan Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Muscle Relaxant Drugs Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Muscle Relaxant Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Muscle Relaxant Drugs Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Muscle Relaxant Drugs Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
Table 69. India Muscle Relaxant Drugs Sales (K Units) by Company (2015-2020)
Table 70. India Muscle Relaxant Drugs Sales Market Share by Company (2015-2020)
Table 71. India Muscle Relaxant Drugs Sales (K Units) by Type (2015-2020)
Table 72. India Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 73. India Muscle Relaxant Drugs Sales (K Units) by Application (2015-2020)
Table 74. India Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Pfizer Muscle Relaxant Drugs Product
Table 79. Pfizer Recent Development
Table 80. Allergan Corporation Information
Table 81. Allergan Description and Business Overview
Table 82. Allergan Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Allergan Muscle Relaxant Drugs Product
Table 84. Allergan Recent Development
Table 85. Ipsen Group Corporation Information
Table 86. Ipsen Group Description and Business Overview
Table 87. Ipsen Group Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Ipsen Group Muscle Relaxant Drugs Product
Table 89. Ipsen Group Recent Development
Table 90. Teva Pharmaceuticals Corporation Information
Table 91. Teva Pharmaceuticals Description and Business Overview
Table 92. Teva Pharmaceuticals Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Teva Pharmaceuticals Muscle Relaxant Drugs Product
Table 94. Teva Pharmaceuticals Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Novartis Muscle Relaxant Drugs Product
Table 99. Novartis Recent Development
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Johnson & Johnson Muscle Relaxant Drugs Product
Table 104. Johnson & Johnson Recent Development
Table 105. Takeda Pharmaceutical Corporation Information
Table 106. Takeda Pharmaceutical Description and Business Overview
Table 107. Takeda Pharmaceutical Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Takeda Pharmaceutical Muscle Relaxant Drugs Product
Table 109. Takeda Pharmaceutical Recent Development
Table 110. Sun Pharmaceutical Industries Corporation Information
Table 111. Sun Pharmaceutical Industries Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Sun Pharmaceutical Industries Description and Business Overview
Table 113. Sun Pharmaceutical Industries Muscle Relaxant Drugs Product
Table 114. Sun Pharmaceutical Industries Recent Development
Table 115. Merz Pharma Corporation Information
Table 116. Merz Pharma Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Merz Pharma Description and Business Overview
Table 118. Merz Pharma Muscle Relaxant Drugs Product
Table 119. Merz Pharma Recent Development
Table 120. Mylan Corporation Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Mylan Muscle Relaxant Drugs Product
Table 124. Mylan Recent Development
Table 125. Fresenius Kabi Corporation Information
Table 126. Fresenius Kabi Description and Business Overview
Table 127. Fresenius Kabi Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Fresenius Kabi Muscle Relaxant Drugs Product
Table 129. Fresenius Kabi Recent Development
Table 130. Endo International Corporation Information
Table 131. Endo International Description and Business Overview
Table 132. Endo International Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Endo International Muscle Relaxant Drugs Product
Table 134. Endo International Recent Development
Table 135. Par Sterile Products Corporation Information
Table 136. Par Sterile Products Description and Business Overview
Table 137. Par Sterile Products Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Par Sterile Products Muscle Relaxant Drugs Product
Table 139. Par Sterile Products Recent Development
Table 140. Acorda Therapeutics Corporation Information
Table 141. Acorda Therapeutics Description and Business Overview
Table 142. Acorda Therapeutics Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Acorda Therapeutics Muscle Relaxant Drugs Product
Table 144. Acorda Therapeutics Recent Development
Table 145. SteriMax Inc Corporation Information
Table 146. SteriMax Inc Description and Business Overview
Table 147. SteriMax Inc Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. SteriMax Inc Muscle Relaxant Drugs Product
Table 149. SteriMax Inc Recent Development
Table 150. Emcure Pharmaceuticals Corporation Information
Table 151. Emcure Pharmaceuticals Description and Business Overview
Table 152. Emcure Pharmaceuticals Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Emcure Pharmaceuticals Muscle Relaxant Drugs Product
Table 154. Emcure Pharmaceuticals Recent Development
Table 155. Upsher-Smith Laboratories Corporation Information
Table 156. Upsher-Smith Laboratories Description and Business Overview
Table 157. Upsher-Smith Laboratories Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Upsher-Smith Laboratories Muscle Relaxant Drugs Product
Table 159. Upsher-Smith Laboratories Recent Development
Table 160. Orient Pharma Corporation Information
Table 161. Orient Pharma Description and Business Overview
Table 162. Orient Pharma Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. Orient Pharma Muscle Relaxant Drugs Product
Table 164. Orient Pharma Recent Development
Table 165. Daewoong Pharmaceutical Corporation Information
Table 166. Daewoong Pharmaceutical Description and Business Overview
Table 167. Daewoong Pharmaceutical Muscle Relaxant Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Daewoong Pharmaceutical Muscle Relaxant Drugs Product
Table 169. Daewoong Pharmaceutical Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Muscle Relaxant Drugs Distributors List
Table 173. Muscle Relaxant Drugs Customers List
Table 174. Muscle Relaxant Drugs Market Key Trends
Table 175. Muscle Relaxant Drugs Key Opportunities and Drivers
Table 176. Muscle Relaxant Drugs Market Challenges
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Muscle Relaxant Drugs Product Picture
Figure 2. Global Muscle Relaxant Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Muscle Relaxant Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Other Examples
Figure 9. Global Muscle Relaxant Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Muscle Relaxant Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Muscle Relaxant Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Muscle Relaxant Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Muscle Relaxant Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Muscle Relaxant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Muscle Relaxant Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Muscle Relaxant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Muscle Relaxant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Muscle Relaxant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Muscle Relaxant Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Muscle Relaxant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Muscle Relaxant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Muscle Relaxant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Muscle Relaxant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Muscle Relaxant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Muscle Relaxant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Muscle Relaxant Drugs Players Market Share by Revenue in Muscle Relaxant Drugs 2015 & 2019
Figure 27. Muscle Relaxant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Muscle Relaxant Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Muscle Relaxant Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Muscle Relaxant Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Muscle Relaxant Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Muscle Relaxant Drugs Sales Market Share by Type in 2019
Figure 33. United States Muscle Relaxant Drugs Sales Market Share by Type in 2019
Figure 34. Europe Muscle Relaxant Drugs Sales Market Share by Company in 2019
Figure 35. Europe Muscle Relaxant Drugs Sales Market Share by Type in 2019
Figure 36. Europe Muscle Relaxant Drugs Sales Market Share by Application in 2019
Figure 37. China Muscle Relaxant Drugs Sales Market Share by Company in 2019
Figure 38. China Muscle Relaxant Drugs Sales Market Share by Type in 2019
Figure 39. China Muscle Relaxant Drugs Sales Market Share by Application in 2019
Figure 40. Japan Muscle Relaxant Drugs Sales Market Share by Company in 2019
Figure 41. Japan Muscle Relaxant Drugs Sales Market Share by Type in 2019
Figure 42. Japan Muscle Relaxant Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Muscle Relaxant Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Muscle Relaxant Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Muscle Relaxant Drugs Sales Market Share by Application in 2019
Figure 46. India Muscle Relaxant Drugs Sales Market Share by Company in 2019
Figure 47. India Muscle Relaxant Drugs Sales Market Share by Type in 2019
Figure 48. India Muscle Relaxant Drugs Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Muscle Relaxant Drugs
Figure 51. Manufacturing Process Analysis of Muscle Relaxant Drugs
Figure 52. Muscle Relaxant Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
電子筋肉刺激装置の世界市場レポート2020 Market Analysis and Insights: Global Electronic Muscle Stimulator Market The global Electronic Muscle Stimulator market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Electronic Muscle Stimulator Scope and Market Size The glo…- 骨盤筋プローブの世界市場レポート2020 Market Analysis and Insights: Global Pelvic Muscle Probe Market The global Pelvic Muscle Probe market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Pelvic Muscle Probe Scope and Market Size The global Pelvic Muscle Probe mar…
- 非ステロイド性抗炎症薬の世界市場レポート2020 Non-steroidal anti-inflammatory drugs refer to a class of drugs that do not contain glucocorticoids and have anti-inflammatory, antipyretic and analgesic effects. It is a first-line drug for the treatment of osteoarthritis and is widely used in other bone and joint diseases, rheumatic and immune dis…
- 麻酔薬・鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Anaesthetic Drugs and Pain Drugs Market The global Anaesthetic Drugs and Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anaesthetic Drugs and Pain Drugs Scope and Market …
- トレプロスチニル薬の世界市場レポート2020 Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following North America, Europe are also very important market with the consumption market share of 6.8…